Nurix Therapeutics, Inc. (NRIX)

26.14 +0.82 (+3.24%) USD  |  NASDAQ  |  Sep 04, 16:00
26.13 -0.01 (-0.04%) After-Hours: 20:00
More

Nurix Therapeutics Annual EPS GAAP Estimates

Annual EPS GAAP Estimates Chart

View Annual EPS GAAP Estimates for NRIX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Annual EPS GAAP Estimates Chart
Start Trial

Historical Annual EPS GAAP Estimates Data

View and export this data back to 2024. Start Trial.
Date Value
November 30, 2028 --
November 30, 2027 --
November 30, 2026 --
Date Value
November 30, 2025 --
November 30, 2024 --

Annual EPS GAAP Estimates Range, Past 5 Years

View Annual EPS GAAP Estimates Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Annual EPS GAAP Estimates Benchmarks

View Annual EPS GAAP Estimates Benchmarks
Start Trial
Monte Rosa Therapeutics, Inc. Upgrade
Gilead Sciences, Inc. Upgrade
TG Therapeutics, Inc. Upgrade
Cue Biopharma, Inc. Upgrade
Keros Therapeutics, Inc. Upgrade